Lupin rises on launching advanced neuro-rehabilitation center 'Atharv Ability' in Delhi
Lupin is currently trading at Rs. 2273.40, up by 15.60 points or 0.69% from its previous closing of Rs. 2257.80 on the BSE.
The scrip opened at Rs. 2276.75 and has touched a high and low of Rs. 2298.30 and Rs. 2255.00 respectively. So far 16289 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2492.00 on 07-May-2026 and a 52 week low of Rs. 1838.65 on 06-Aug-2025.
Last one week high and low of the scrip stood at Rs. 2,492.00 and Rs. 2210.80 respectively. The current market cap of the company is Rs. 103879.44 crore.
The promoters holding in the company stood at 46.86%, while Institutions and Non-Institutions held 47.03% and 6.11% respectively.
Lupin has launched Atharv Ability, its world-class neuro-rehabilitation center in Naraina Vihar, Delhi, dedicated to delivering comprehensive, outcome-driven, specialized, and multidisciplinary care for adults and children with neurological disabilities - enhancing mobility, improving quality of life, and supporting long-term recovery.
Atharv Ability stands at the forefront of advanced neuro-rehabilitation, combining clinical expertise, technological precision, and personalized care programs to bridge critical treatment gaps across a wide spectrum of conditions - including stroke, traumatic brain injury, spinal cord injury, Parkinson’s disease, multiple sclerosis, and pediatric neurological disorders such as cerebral palsy.
Following the successful launch of its centers in Mumbai in 2023 and Hyderabad in 2024, Atharv Ability’s Delhi facility seeks to expand access to integrated, high-quality neuro-rehabilitation care in a region where such specialized services remain limited.
